Cost of Hypoglycemia in Patients with Type 2 Diabetes in Sweden

Value in Health - Tập 9 - Trang 193-198 - 2006
Linus Jönsson1, Björn Bolinder2, Jonas Lundkvist3
1Stockholm Health Economics, Stockholm, Sweden
2Aventis Pharma, Bridgewater, NJ, USA
3Medical Management Center, Karolinska Institutet, Stockholm, Sweden

Tài liệu tham khảo

Henriksson, 2000, Direct medical costs for patients with type 2 diabetes in Sweden, J Intern Med, 248, 387, 10.1046/j.1365-2796.2000.00749.x WHO Henriksson, 1998, Diabetes: the cost of illness in Sweden, J Intern Med, 2446, 461, 10.1111/j.1365-2796.1998.00388.x Henriksson, 1999, Health economics analysis of diabetes is necessary. It facilitates decision-making and international comparison, Lakartidningen, 96, 3915 UK Prospective Diabetes Study (UKPDS) Group, 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 The Diabetes Control and Complications Trial Research Group, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 Cryer, 1999, Hypoglycemia is the limiting factor in the management of diabetes, Diabetes Metab Res Rev, 15, 42, 10.1002/(SICI)1520-7560(199901/02)15:1<42::AID-DMRR1>3.0.CO;2-B Miller, 2001, Hypoglycemia in patients with type 2 diabetes mellitus, Arch Intern Med, 161, 1653, 10.1001/archinte.161.13.1653 Frier, 2002, Hypoglycaemic valleys: an under-recognised problem in type 2 diabetes?, Int J Clin Pract, 129, S12 United Kingdom Prospective Diabetes Study Group, 1998, United Kingdom Prospective Diabetes Study 24. A 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy, Ann Intern Med, 128, 165, 10.7326/0003-4819-128-3-199802010-00001 Cryer, 2002, Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes, Diabetologia, 45, 937, 10.1007/s00125-002-0822-9 McCrimmon, 1994, Hypoglycaemia, the most feared complication of insulin therapy, Diabetes Metab, 20, 503 Leese, 2003, Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use, Diabetes Care, 26, 1176, 10.2337/diacare.26.4.1176 Allicar, 2000, Augendre-Ferrante B. Frequency and costs of hospital stays for hypoglycemia in France in 1995, Presse Med, 29, 657 Holstein, 2002, Incidence and costs of severe hypoglycemia, Diabetes Care, 25, 2109, 10.2337/diacare.25.11.2109 Hodgson, 1982, Cost-of-illness methodology: a guide to current practices and procedures, Milbank Mem Fund Q Health Soc, 60, 429, 10.2307/3349801 Rice, 1967, Estimating the cost of illness, Am J Public Health Nations Health, 57, 424, 10.2105/AJPH.57.3.424 Gold, 1994, Frequency of severe hypoglycaemia in patients with Type I diabetes with impaired awareness of hypoglycaemia, Diabetes Care, 17, 697, 10.2337/diacare.17.7.697 O'Brien, 1998, Direct medical costs of complications resulting from type 2 diabetes in the U.S., Diabetes Care, 21, 1122, 10.2337/diacare.21.7.1122 LINFO, 2001 Nordfeldt, 2001, Short-term effects of severe hypoglycaemia in children and adolescents with type 1 diabetes. A cost-of-illness study, Acta Paediatr, 90, 137, 10.1111/j.1651-2227.2001.tb00274.x Statistic Sweden, 2003 1995, Resource utilization and costs of care in the diabetes control and complications trial, Diabetes Care, 18, 1468, 10.2337/diacare.18.11.1468 van Staa, 1997, Rates of hypoglycemia in users of sulfonylureas, J Clin Epidemiol, 50, 735, 10.1016/S0895-4356(97)00024-3